Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031

VTE

Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
May 9, 2026, 14:10 | Science
Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of…
Alyaa Al-Mughairy: First Pediatric Case of Successful DOAC Treatment in a Clinical Setting
May 8, 2026, 12:42 | Voices
Alyaa Al-Mughairy: First Pediatric Case of Successful DOAC Treatment in a Clinical Setting
Alyaa Al-Mughairy, Pediatric Hematology Oncology Senior Consultant at Ministry of Health Oman,and National Oncology Centre…
Risk-Stratified HRT Use Following VTE - NBCA
May 8, 2026, 06:03 | Voices
Risk-Stratified HRT Use Following VTE - NBCA
NBCA shared a post on X: "The blanket 'no HRT after VTE' approach is being…
Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
May 6, 2026, 12:12 | Voices
Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
Mona Ranade, Clinical Associate Professor at Stanford University, shared on LinkedIn: ''If you’re interested in…
Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
May 5, 2026, 13:20 | Voices
Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at…
VTE Prophylaxis in Post-Acute Care - RPTH Journal
May 5, 2026, 12:46 | Science
VTE Prophylaxis in Post-Acute Care - RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Pil Joo et al., adding: "VTE…
Ney Carter Borges: Sex Hormone Therapy and Thrombotic Risk - Balancing Benefits and Risks
May 4, 2026, 10:17 | Voices
Ney Carter Borges: Sex Hormone Therapy and Thrombotic Risk - Balancing Benefits and Risks
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a…
Dominique Stephan: Recreational Nitrous Oxide Use as a Risk Factor for VTE
May 4, 2026, 08:15 | Science
Dominique Stephan: Recreational Nitrous Oxide Use as a Risk Factor for VTE
Dominique Stephan, Professor at Strasbourg Hospital University, shared a post on LinkedIn about a recent…
Vera Ignjatović: Why Is Thrombosis Research So Far Behind When It Comes to AI and Multi-Omics?
May 4, 2026, 06:45 | Science
Vera Ignjatović: Why Is Thrombosis Research So Far Behind When It Comes to AI and Multi-Omics?
Vera Ignjatović, Founder and Managing Director at Ignis Innovations Pty Ltd, Principal Consultant of Translational…
Erin VanDyke: Excited to See Continued Momentum Around VTE Program Development
May 3, 2026, 04:36 | Voices
Erin VanDyke: Excited to See Continued Momentum Around VTE Program Development
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared a post on LinkedIn: ''First…
Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
May 1, 2026, 14:32 | Voices
Mark Crowther: Evidence-Based Guidance for Anticoagulant Prophylaxis in Children
Mark Crowther, University Professor and Chair, Department of Medicine at McMaster University, Fellow at Canadian…
Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC
Apr 30, 2026, 16:56 | Voices
Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC
Oliver Maracic, Independent Oncology and Metabolic Disease Strategist, shared a post on LinkedIn about a…
The Gap Between Clinical Assessment and Patient Experience in VTE - RPTH Journal
Apr 30, 2026, 13:23 | Science
The Gap Between Clinical Assessment and Patient Experience in VTE - RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Anette Arbjerg Højen…
Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
Apr 28, 2026, 13:23 | Science
Piotr Czempik: Anti-Xa-Guided Enoxaparin Prophylaxis in Extreme Obesity
Piotr Czempik, Chair of Department of Anesthesiology and Intensive Care at Medical University of Silesia,…
Shek Sady Khan: Addressing the Silent Burden of Venous Thromboembolism in Bangladesh
Apr 27, 2026, 20:25 | Science
Shek Sady Khan: Addressing the Silent Burden of Venous Thromboembolism in Bangladesh
Shek Sady Khan, Medical Affairs and Strategic Initiatives Manager at Servier in Bangladesh, shared on…
Anthony Wright: Standing with Stop the Clot at Payne Day 2026
Apr 27, 2026, 14:00 | Voices
Anthony Wright: Standing with Stop the Clot at Payne Day 2026
Anthony Wright, General Manager at Port Royal Brands, shared on LinkedIn: ''We had the best…
Mital Jhaveri: The Promise of Factor XI Inhibitors in Chronic Kidney Disease
Apr 27, 2026, 13:36 | Science
Mital Jhaveri: The Promise of Factor XI Inhibitors in Chronic Kidney Disease
Mital Jhaveri, Clinical Anticoagulation, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared on…
Pedro Perez: Are We Measuring the Right Outcomes in VTE?
Apr 24, 2026, 23:36 | Voices
Pedro Perez: Are We Measuring the Right Outcomes in VTE?
Pedro Perez, Senior Vascular Consultant at Argon Medical Devices, Inc., shared a post on LinkedIn:…
Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
Apr 23, 2026, 16:55 | Voices
Neda K.: When to Hold Antithrombotics and Use Bridging Therapy in Surgery
Neda K., Clinical Pharmacist, shared a post on LinkedIn: ''Perioperative Management of Antithrombotic: When to…
Michael Wong: Predicting Blood Clots is a Patient Safety Issue
Apr 22, 2026, 07:02 | Insight
Michael Wong: Predicting Blood Clots is a Patient Safety Issue
Michael Wong, Founder and Executive Director at Physician-Patient Alliance for Health and Safety, Board Member…
Ana Pedrero Gil: New ASH–ISTH 2026 Guidelines Focus on Preventing VTE in Children
Apr 21, 2026, 18:35 | Science
Ana Pedrero Gil: New ASH–ISTH 2026 Guidelines Focus on Preventing VTE in Children
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by…
Danny Hsu: Are We Underestimating Postpartum VTE Risk?
Apr 21, 2026, 15:26 | Voices
Danny Hsu: Are We Underestimating Postpartum VTE Risk?
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South…
Chokri Ben Lamine: 50 Pearls Credits on How is Breakthrough Thrombosis in Patients with Cancer Being Treated
Apr 21, 2026, 14:36 | Voices
Chokri Ben Lamine: 50 Pearls Credits on How is Breakthrough Thrombosis in Patients with Cancer Being Treated
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Mary Cushman: Unprovoked VTE as a Marker of Increased Cardiovascular Mortality Risk
Apr 19, 2026, 13:41 | Science
Mary Cushman: Unprovoked VTE as a Marker of Increased Cardiovascular Mortality Risk
Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont, shared Debora…
Mohammed M. Aboudeif: The Decision-Making Process for Anticoagulation in Stroke
Apr 18, 2026, 13:16 | Insight
Mohammed M. Aboudeif: The Decision-Making Process for Anticoagulation in Stroke
Mohammed M. Aboudeif, Critical Care Registrar at King AbdulAziz University, shared on LinkedIn: ''Timing is…
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Apr 17, 2026, 12:44 | Science
Marc Carrier: A Practical Approach to Recurrent Thrombosis in Cancer Patients
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a…
Are We Underestimating VTE After PanNET Surgery? - RPTH Journal
Apr 16, 2026, 18:27 | Science
Are We Underestimating VTE After PanNET Surgery? - RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Kelly Dong et…
Mysa Saad: Antiplatelets Increase Bleeding Without Reducing VTE in Cancer Patients
Apr 16, 2026, 04:13 | Science
Mysa Saad: Antiplatelets Increase Bleeding Without Reducing VTE in Cancer Patients
Mysa Saad, Internal Medicine Resident shared a post on LinkedIn about a recent article she…
Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events - Key Clinical Pearls
Apr 15, 2026, 16:55 | Voices
Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events - Key Clinical Pearls
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Donald Correll: Key Risk Factors for Venous Thromboembolism
Apr 15, 2026, 14:55 | Voices
Donald Correll: Key Risk Factors for Venous Thromboembolism
Donald Correll, Telemedicine Physician at Teladoc Health, shared a post on LinkedIn: "Flashcards from Physician…
Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins
Apr 15, 2026, 14:29 | Voices
Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared…
Prince Alfred Singh։ Understanding Antithrombin III Deficiency as a High-Risk Thrombophilia
Apr 15, 2026, 14:25 | Voices
Prince Alfred Singh։ Understanding Antithrombin III Deficiency as a High-Risk Thrombophilia
Prince Alfred Singh, Medical Officer at Addu Equatorial Hospital (AEH), shared a post on LinkedIn:…
Erin VanDyke: Next Generation Is Leading the Way in Pediatric VTE Care
Apr 15, 2026, 14:16 | Voices
Erin VanDyke: Next Generation Is Leading the Way in Pediatric VTE Care
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared a post on LinkedIn: ''Kids…
Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
Apr 15, 2026, 04:52 | Science
Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
Ulrich Pecks, Head of Obstetrics and Maternal Health and Fetal Development at University Hospital Würzburg,…
Marc Carrier: The Vermont Model Demonstrates the Power of VTE Prevention
Apr 13, 2026, 12:48 | Science
Marc Carrier: The Vermont Model Demonstrates the Power of VTE Prevention
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared a post on LinkedIn about a recent…
The Case for Greater Investment in VTE Research - JTH
Apr 13, 2026, 07:58 | Science
The Case for Greater Investment in VTE Research - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Ryan Coute…
Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
Apr 12, 2026, 15:26 | Voices
Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
Melissa Lewellyn, Director of Strategic Growth, Consulting at Manatt, Phelps and Phillips, LLP, shared on…
Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
Apr 12, 2026, 14:58 | Science
Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
Akram Shibani, Medical Director of Pulmonary and Critical Service Line at Ascension St. Vincent's, shared…
Emmanuel J Favaloro: D-dimer testing in VTE diagnostic management studies
Apr 12, 2026, 13:38 | Science
Emmanuel J Favaloro: D-dimer testing in VTE diagnostic management studies
Emmanuel J Favaloro, Editor in Chief at Seminars in Thrombosis and Hemostasis, shared a post…
Can We Better Predict Who Is Most Likely to Have Another VTE After a First Event? - RPTH Journal
Apr 12, 2026, 13:21 | Science
Can We Better Predict Who Is Most Likely to Have Another VTE After a First Event? - RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Eugenia Biguzzi, adding: ''Can we better…
Chokri Ben Lamine: Clinical Dosing and Special Populations Guide for Apixaban
Apr 12, 2026, 12:56 | Voices
Chokri Ben Lamine: Clinical Dosing and Special Populations Guide for Apixaban
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
Apr 10, 2026, 17:47 | Voices
Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
Lucie Raskin, PhD student at University of Namur, shared on LinkedIn: ''Glad to have presented…
New Clinical Practice Guideline on Anticoagulant Prophylaxis in Pediatric Patients at Risk of VTE - ISTH
Apr 9, 2026, 18:21 | Science
New Clinical Practice Guideline on Anticoagulant Prophylaxis in Pediatric Patients at Risk of VTE - ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn: NEWS: The American Society of…
National Institutes of Health Addresses VTE Research Funding Gap - JTH
Apr 9, 2026, 15:09 | Science
National Institutes of Health Addresses VTE Research Funding Gap - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Gregory Piazza: The Rationale and Methods Behind the New AHA/ACC PE Guidelines Clinical Categories
Apr 8, 2026, 14:37 | Science
Gregory Piazza: The Rationale and Methods Behind the New AHA/ACC PE Guidelines Clinical Categories
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, shared a…
Chokri Ben Lamine: Anticoagulation Switching Pearls
Apr 8, 2026, 14:17 | Voices
Chokri Ben Lamine: Anticoagulation Switching Pearls
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Francisco Chacón-Lozsán: Bleeding on Anticoagulation Is Not a Complication, It’s a Turning Point
Apr 8, 2026, 14:13 | Science
Francisco Chacón-Lozsán: Bleeding on Anticoagulation Is Not a Complication, It’s a Turning Point
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine…
Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
Apr 7, 2026, 17:30 | Voices
Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Tumor Mutations and VTE Risk - New Insights from a 12,500-Patient Cancer Study - JTH
Apr 6, 2026, 16:34 | Science
Tumor Mutations and VTE Risk - New Insights from a 12,500-Patient Cancer Study - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home
Apr 6, 2026, 10:49 | Voices
Chokri Ben Lamine: Routine VTE Prophylaxis Is Not Recommended for Chronically Bedridden Patients at Home
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at…
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Apr 5, 2026, 16:16 | Voices
Sthanu Subramanian։ Understanding Antiphospholipid Syndrome and Its Thrombotic Risks
Sthanu Subramanian, Pediatrician, shared a post on X: ''Antiphospholipid Syndrome (APS), also known as Hughes'…
Marc Turner: VETERANSFirst, CHAMPION-AF Trial, and HI-PEITHO Trial Driving Innovation at ACC26
Apr 4, 2026, 17:56 | Insight
Marc Turner: VETERANSFirst, CHAMPION-AF Trial, and HI-PEITHO Trial Driving Innovation at ACC26
Marc Turner, SVP for US Corporate Accounts and Healthcare Solutions at Boston Scientific, shared on…
Shahab Sheikhalishahi: A Rare Case of Portal Vein Thrombosis After Echis Carinatus Envenomation
Apr 3, 2026, 17:38 | Science
Shahab Sheikhalishahi: A Rare Case of Portal Vein Thrombosis After Echis Carinatus Envenomation
Shahab Sheikhalishahi, Medical Student and Clinical Researcher at Shahid Sadoughi University of Medical Sciences and…
Yves Bikorimana: When More Is Not Better - Polycythemia
Apr 3, 2026, 17:14 | Voices
Yves Bikorimana: When More Is Not Better - Polycythemia
Yves Bikorimana, CEO at MedData - Rwanda and Lab Scientist at The University Teaching Hospital…
Erin VanDyke: Progress, Partnerships, and Patient Impact in VTE Care
Apr 3, 2026, 13:44 | Voices
Erin VanDyke: Progress, Partnerships, and Patient Impact in VTE Care
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared a post on LinkedIn: "PHEW…March did…
Niyas Khalid: A Rare Case of Venous Ischemic Pancreatitis Redefining Diagnosis
Apr 2, 2026, 18:32 | Science
Niyas Khalid: A Rare Case of Venous Ischemic Pancreatitis Redefining Diagnosis
Niyas Khalid, Head of Department of Inpatient Care at Burjeel Hospital, shared on LinkedIn about a…
Johns Hopkins All Children's Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence - NBCA
Apr 1, 2026, 21:00 | Voices
Johns Hopkins All Children's Hospital Becomes The 1st U.S Pediatric VTE Center of Excellence - NBCA
National Blood Clot Alliance shared a post on LinkedIn: ''A first for pediatric blood clot…
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Apr 1, 2026, 17:21 | Science
Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
Antonio Pineda Guerrero, Research Trainee at INIT-UJI, shared a post on LinkedIn about a recent…
John Abraham: Breaking the 'Bleeding Disorder' Myth About Cirrhosis and Coagulation
Apr 1, 2026, 17:18 | Science
John Abraham: Breaking the 'Bleeding Disorder' Myth About Cirrhosis and Coagulation
John Abraham, Assistant Professor at Christian Medical College and Hospital, shared a post on Linkedin…
Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE
Mar 30, 2026, 17:40 | Science
Sajjad Ullah Mphil: The Impact of Pharmacist-Led Anticoagulation Care in VTE
Sajjad Ullah Mphil, Pharmacist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on…
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Mar 30, 2026, 17:25 | Science
Maria Angelica Pabon: LPA Relation to VTE Appears To Be Hormone-Dependent
Maria Angelica Pabon, Cardiologist at Brigham and Women's Hospital, shared on LinkedIn about a recent article…
Karim Ahmed: Why The Right DOAC Choice Still Depends on The Patient
Mar 29, 2026, 11:40 | Voices
Karim Ahmed: Why The Right DOAC Choice Still Depends on The Patient
Karim Ahmed, Clinical Pharmacist at Palm Beach Accountable Care Organization, shared a post on LinkedIn:…
Christoph B. Olivier: What If We Reduce Cardiovascular Collapse in PE by 60% Without Increasing Bleeding?
Mar 29, 2026, 06:11 | Science
Christoph B. Olivier: What If We Reduce Cardiovascular Collapse in PE by 60% Without Increasing Bleeding?
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn about a…
A Call for Targeted Prevention of Postthrombotic Syndrome in Europe - JTH
Mar 29, 2026, 06:06 | Science
A Call for Targeted Prevention of Postthrombotic Syndrome in Europe - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Amy Delderfield: One Trial, Big Implications for Anticoagulant Choice
Mar 28, 2026, 18:41 | Voices
Amy Delderfield: One Trial, Big Implications for Anticoagulant Choice
Amy Delderfield, Founder of Medicine Central, STEM Advisor to the UN, shared a post on…
Christian Schulze: HI-PEITHO Shows Strong Benefit of Catheter-Based Local Thrombolysis in PE
Mar 28, 2026, 15:55 | Science
Christian Schulze: HI-PEITHO Shows Strong Benefit of Catheter-Based Local Thrombolysis in PE
Christian Schulze, Professor of Medicine at Friedrich-Schiller-University Jena, shared on LinkedIn about a recent article…
Predictors, Trajectories, and Quality of Life Outcomes in Pulmonary Embolism Recovery - JTH
Mar 28, 2026, 15:49 | Science
Predictors, Trajectories, and Quality of Life Outcomes in Pulmonary Embolism Recovery - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Heghine Khachatryan: Persistent Risks of Venous Thromboembolism in Pregnancy and Postpartum
Mar 27, 2026, 17:43 | Voices
Heghine Khachatryan: Persistent Risks of Venous Thromboembolism in Pregnancy and Postpartum
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients - JTH
Mar 27, 2026, 16:58 | Science
Promising Thrombin Biomarkers For Identifying High-Risk VTE Patients - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Anu Anna Babu: Which DOAC is Safer for Patients With Acute Venous Thromboembolism?
Mar 26, 2026, 16:56 | Science
Anu Anna Babu: Which DOAC is Safer for Patients With Acute Venous Thromboembolism?
Anu Anna Babu, Clinical Pharmacist Intern at Believers Church Medical College Hospital, shared a post…
Rodrigo Assar: Thrombosis Risk Prediction in Pediatric Central Lines
Mar 26, 2026, 15:14 | Science
Rodrigo Assar: Thrombosis Risk Prediction in Pediatric Central Lines
Rodrigo Assar, Senior Data Scientist at Globant, shared a post on LinkedIn about a recent…
Alfonso J. Tafur: We Need to Rethink What Drives Disparities in Blood Clot Outcomes
Mar 26, 2026, 14:48 | Science
Alfonso J. Tafur: We Need to Rethink What Drives Disparities in Blood Clot Outcomes
Alfonso J. Tafur, Vascular Medicine Fellowship Program Director at University of Chicago, Director of Vascular…
Rick Matthews: A Milestone in DVT Treatment and Patient Access from Vein and Vascular Institute and NBCA
Mar 25, 2026, 15:00 | Voices
Rick Matthews: A Milestone in DVT Treatment and Patient Access from Vein and Vascular Institute and NBCA
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., reposted from National Blood Clot…
Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
Mar 24, 2026, 17:09 | Voices
Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
Marcos Gamboa Chele, Internal Medicine Specialist, shared a post on LinkedIn about a recent article…
Mazou Ngou Temgoua: Why Does Apixaban Cause Less Bleeding than Rivaroxaban?
Mar 23, 2026, 15:46 | Science
Mazou Ngou Temgoua: Why Does Apixaban Cause Less Bleeding than Rivaroxaban?
Mazou Ngou Temgoua, Contract hospital practitioner at Châteauroux-Le Blanc Hospital Center, shared on LinkedIn about a…
Ala Eddin Sagar: Apixaban vs Rivaroxaban on This Week in Pulmonary and Critical Care Medicine
Mar 22, 2026, 16:21 | Insight
Ala Eddin Sagar: Apixaban vs Rivaroxaban on This Week in Pulmonary and Critical Care Medicine
Ala Eddin Sagar, Interventional Pulmonologist at King Faisal Specialist Hospital and Research Center - Madinah,…
Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
Mar 22, 2026, 14:46 | Voices
Francisco Chacón-Lozsán: PE Is The New STEMI, But Are We Treating It Too Aggressively?
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine…
Hussien Hishmat: Pulmonary Embolism - How Does Risk Dictate Management
Mar 22, 2026, 14:26 | Insight
Hussien Hishmat: Pulmonary Embolism - How Does Risk Dictate Management
Hussien Hishmat, Professor at Cairo University, Consultant interventional cardiologist at Tadawi Healthcare, Fellow at European…
María Florencia Giannini: Diagnosis and Management of VTE in Pregnancy and Postpartum
Mar 22, 2026, 12:48 | Science
María Florencia Giannini: Diagnosis and Management of VTE in Pregnancy and Postpartum
María Florencia Giannini Cardiologist at Moron Municipal Hospital shared a post on LinkedIn about a…
Francisco Chacón-Lozsán: Insights on Intermediate High Risk Pulmonary Embolism from ACVC 2026
Mar 21, 2026, 16:47 | Insight
Francisco Chacón-Lozsán: Insights on Intermediate High Risk Pulmonary Embolism from ACVC 2026
Francisco Chacón-Lozsán, Fellow at World Extreme Medicine, Member of European Society of Intensive Care Medicine…
Sebastian Szmit: Latest Insights into VTE Management in Cancer Patients
Mar 21, 2026, 15:46 | Voices
Sebastian Szmit: Latest Insights into VTE Management in Cancer Patients
Sebastian Szmit, Head of Department of Cardio-Oncology, Centrum Medycznego Kształcenia Podyplomowego, shared a post on LinkedIn about…
Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
Mar 20, 2026, 17:35 | Science
Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
Bawan Ahmed, Lecturer at University of Greenwich, shared a post on LinkedIn about a recent…
Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE - JTH
Mar 20, 2026, 16:26 | Science
Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE - JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article…
Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
Mar 19, 2026, 15:29 | Voices
Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center,…
Andrea Van Beek: Improving DOAC Adherence Saves Lives
Mar 17, 2026, 17:48 | Voices
Andrea Van Beek: Improving DOAC Adherence Saves Lives
Andrea Van Beek, Board of Directors of Anticoagulation Forum, National Certification Board for Anticoagulation Providers,…
Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease - RPTH
Mar 16, 2026, 19:03 | Science
Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease - RPTH
RPTH Journal shared on LinkedIn about a recent article by Mosaad Almegren et al, adding: ''What’s…
Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
Mar 16, 2026, 18:59 | Science
Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
Bartosz Hudzik, Associate Profesor at Medical University of Silesia, shared a post on LinkedIn about…
Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
Mar 16, 2026, 16:14 | Voices
Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
Siobhan Calafiore, Senior Journalist at the limbic, shared a post on LinkedIn about a recent…
Abdulrahman Nasiri: Most Important Concepts and the Clinical Shift the COBRRA Trial Brings to Practice
Mar 14, 2026, 14:45 | Voices
Abdulrahman Nasiri: Most Important Concepts and the Clinical Shift the COBRRA Trial Brings to Practice
Abdulrahman Nasiri, Assistant Professor of Medicine and Hematology at Imam Mohammad Ibn Saud Islamic University,…
Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
Mar 13, 2026, 20:11 | Insight
Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
Christoph B. Olivier, Head of the Clinical Trials Unit, UHZ Freiburg, shared on LinkedIn, adding:…
Julie Cardoso: Bringing Clinicians Together to Improve VTE Detection and Treatment
Mar 13, 2026, 14:10 | Voices
Julie Cardoso: Bringing Clinicians Together to Improve VTE Detection and Treatment
Julie Cardoso, Owner and Executive Director of Independent Diagnostic Testing Facility at Universal Ultrasound Diagnostics,…
Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
Mar 13, 2026, 11:36 | Voices
Alfonso Tafur: The Data Behind Cancer-Associated Thrombosis
Alfonso Tafur, Vascular Medicine Fellowship Program Director at the University of Chicago, Director of Vascular…
Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
Mar 13, 2026, 10:00 | Voices
Mandy Lauw: Can Reduced-Dose DOACs Be Applied to All Patients With VTE?
Mandy Lauw, Internist-hematologist at Erasmus MC, shared a post on LinkedIn about a recent article…
Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority
Mar 11, 2026, 23:05 | Science
Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a…
The Results of Landmark COBRRA Trial in Acute VTE Management - ISTH
Mar 11, 2026, 22:01 | Science
The Results of Landmark COBRRA Trial in Acute VTE Management - ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn about a recent article…
Heghine Khachatryan։ Age-Adjusted D-Dimer Thresholds for Safer and Smarter VTE Rule-Out
Mar 10, 2026, 12:41 | Voices
Heghine Khachatryan։ Age-Adjusted D-Dimer Thresholds for Safer and Smarter VTE Rule-Out
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology…
Roberta Gualtierotti: How Do Sex and Gender Influence VTE in Patients with Cancer?
Mar 10, 2026, 12:39 | Science
Roberta Gualtierotti: How Do Sex and Gender Influence VTE in Patients with Cancer?
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, posted on LinkedIn about…
Alfonso Tafur: Different Cancer Sites Drive Different Thrombotic Phenotypes
Mar 9, 2026, 15:30 | Voices
Alfonso Tafur: Different Cancer Sites Drive Different Thrombotic Phenotypes
Alfonso Tafur, Vascular Medicine Fellowship Program Director at University of Chicago, Director of Vascular Medicine…
Zeeshan Ahmed Khattak: Certification Pathways in Anticoagulation for Pharmacists
Mar 9, 2026, 15:24 | Voices
Zeeshan Ahmed Khattak: Certification Pathways in Anticoagulation for Pharmacists
Zeeshan Ahmed Khattak, Pharmacist (IP/Oncology) at Abu Dhabi Stem Cells Center, shared on LinkedIn: ''Certifications…
Rick Matthews: Looking Beyond Clot Clearance in Long-Term Management After DVT
Mar 9, 2026, 13:49 | Voices
Rick Matthews: Looking Beyond Clot Clearance in Long-Term Management After DVT
Rick Matthews, Senior Vascular Consultant at Argon Medical Devices, Inc., shared on LinkedIn: ''We talk…
All: 347 Posts: 1 - 100
NewsFeed